This research aims to provide clinicians with non-invasive, user-friendly tools to detect diseases early, track their progression, and deliver treatments tailored to each patient. We study physiological signals such as speech, movement, and handwriting that can serve as biomarkers for distinguishing among different brain diseases.
Because disorders like Alzheimer’s and Parkinson’s often appear similar in the early stages, identifying their unique characteristics is essential. Our work also investigates how neurodegenerative diseases differ from frailty syndromes, which affect physical strength, independence, and quality of life in older adults.
Through these efforts, we seek to improve outcomes for elderly patients while reducing the healthcare burden of neurodegenerative disease and frailty.